Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Astrazeneca Plc ADR (NQ: AZN )

71.03 +0.18 (+0.25%)
Streaming Delayed Price Updated: 3:13 PM EDT, Apr 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Astrazeneca Plc ADR

< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
42 43 Next >
70 Firms Going Ex-Dividend Next Week, Including GlaxoSmithKline, Dow And AstraZeneca
Ex-dividend dates are important to dividend investors because one must own a stock prior to its ex-dividend date in order to be eligible to receive its next dividend. 
Via Talk Markets
GSK Halts Late-Stage RSV Vaccine Trial In Pregnant Women
GlaxoSmithKline plc (NYSE: GSK) has paused a late-stage trial of its respiratory syncytial virus (RSV) vaccine candidate in pregnant women based on safety... 
Via Benzinga
The Daily Biotech Pulse: Regeneron-Sanofi Halt Late-Stage Dupixent Study, Agios Gets FDA Nod, Safety Scare For GSK's RSV Vaccine, Shockwave Jumps On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Agios's Metabolic Disorder Treatment Receives FDA Approval (NASDAQ: AGIO... 
Via Benzinga
Biotech Stocks Are Down And Out; Can These 2022 Trends Save Them?
Can the formerly red-hot biotech segment return to its previous glory? 
Via Investor's Business Daily
AstraZeneca: Q4 Earnings Insights
  AstraZeneca (NASDAQ:AZN) reported its Q4 earnings results on Thursday, February 10, 2022 at 02:15 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Scheduled For February 10, 2022
Companies Reporting Before The Bell • Canada Goose Hldgs (NYSE:GOOS) is projected to report quarterly earnings at $1.46 per share on revenue of $584.49 million. 
Via Benzinga
Short Shelf Life Of AstraZeneca's COVID-19 Shot Entangles Vaccine Rollout In Poorer Nations: Reuters
According to officials and internal World Health Organization documents reviewed by Reuters, the relatively short shelf life of AstraZeneca Plc's (NASDAQ: AZN)... 
Via Benzinga
The Daily Biotech Pulse: Avenue Tumbles On Negative Adcom Verdict, Moderna's Expanded Deal With Rovi, Gilead Takes Equity Stake In Hookipa
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Hookipa Gets $15M Upfront Payment And Equity Investment From Gilead Following... 
Via Benzinga
A Peek Into The Markets: US Stock Futures Edge Higher Ahead Of Economic Data, Fed Minutes
Pre-open movers 
Via Benzinga
Why Are AstraZeneca Shares Trading Higher Today
Adding AstraZeneca Plc's (NASDAQ: AZN) Lynparza to Johnson & Johnson's (NYSE: JNJ) Zytiga (abiraterone) extended the time to live without disease... 
Via Benzinga
AstraZeneca Stock Ranked No. 1 In Group; Recently Reported Record Sales, Strong Outlook
AstraZeneca reported record sales, and a bullish outlook. AstraZeneca stock is idling though amid market weakness. Setting up for run higher? 
Via Investor's Business Daily
Large Cap Biopharma- Well Positioned For Choppy Markets
If the past week is any indicator large-cap biopharma stocks are a good place to hide from the turbulence of 2022 markets. 
Via Talk Markets
The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More
Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news flow continued to dominate... 
Via Talk Markets
The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More
Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news... 
Via Benzinga
Stock Market Rally Stalls As Inflation, Treasury Yields Soar: Weekly Review
The stock market rally remains stuck in a recent range as the major indexes slashed weekly gains on hot inflation. Treasury yields surged. 
Via Investor's Business Daily
Two Insider Moonshots Rising on Sudden Buying
Biotech insiders are among the most important investors to pay close attention to. Here are two that show good signs for the future. 
Via InvestorPlace
42 Stocks Moving In Thursday's Mid-Day Session
Gainers American Rebel Holdings, Inc. (NASDAQ: AREB) shares climbed 63.3% to $3.45 following the company's recent uplisting to the Nasdaq. BRC Inc. (NYSE: BRCC) climbed 35.8... 
Via Benzinga
Seagen Crumbles With AstraZeneca Expected To Pressure Its New Drug
Seagen called for lower-than-expected 2022 sales of Tukysa, a breast cancer drug. 
Via Investor's Business Daily
The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
AstraZeneca Records Bumper COVID-19 Vaccine Sales Of $4B In FY21
Core earnings per share (EPS) came in at $1.67, topping estimates of $0.73. 
Via Talk Markets
21 Stocks Moving in Thursday's Pre-Market Session
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep. Also check out this: Executives Sell More Than $210M Of 5... 
Via Benzinga
AstraZeneca Records Bumper COVID-19 Vaccine Sales Of ~$4B In FY21
AstraZeneca Plc's (NASDAQ: AZN) total revenue jumped 63% Y/Y to $12.0 
Via Benzinga
Take a Leap Into Novavax Stock After Vaccine Sales Start
Novavax is worth speculating on at current levels. NVAX stock has fallen below the $100 mark ahead of its global Covid-19 vaccine launch. 
Via InvestorPlace
EYES Stock Pops on Biotech Merger Plans. 5 Things to Know.
EYES stock is up 15% today on news that Second Sight Medical is making a strategic acquisition. Here's what to know. 
Via InvestorPlace
Second Sight Medical To Merge With AstraZeneca-Backed Nano Precision Medical
Second Sight Medical Products Inc (NASDAQ: EYES) will acquire privately-held Nano Precision Medical Inc in an all-stock transaction. Second Sight Medical... 
Via Benzinga
Key Events This Week: All Eyes On The CPI
After what DB's Jim Reid describes as 
Via Talk Markets
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big... 
Via Benzinga
AstraZeneca Dumps Off Mid-Stage Cardiovascular Drug To Regio Biosciences
AstraZeneca plc (NASDAQ: AZN) has granted  
Via Benzinga
4 Great Global Stocks to Buy for a Diversified Portfolio
Global stocks that are worth holding for the long-term for a well-diversified portfolio. High growth global stocks with strong fundamentals. 
Via InvestorPlace
Avoid Novavax for Now, Until the Picture Clears Up
NVAX stock may have seen a near-term bounce following the completion of filing of EUA filing with the FDA, but it may not be a buy yet. 
Via InvestorPlace
< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
42 43 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.